Susquehanna Portfolio Strategies, LLC Moderna, Inc. Transaction History
Susquehanna Portfolio Strategies, LLC
- $4.58 Trillion
- Q2 2025
A detailed history of Susquehanna Portfolio Strategies, LLC transactions in Moderna, Inc. stock. As of the latest transaction made, Susquehanna Portfolio Strategies, LLC holds 78,800 shares of MRNA stock, worth $1.93 Million. This represents 0.05% of its overall portfolio holdings.
Number of Shares
78,800Holding current value
$1.93 Million% of portfolio
0.05%Shares
1 transactions
Others Institutions Holding MRNA
# of Institutions
848Shares Held
265MCall Options Held
28.5MPut Options Held
35M-
Vanguard Group Inc Valley Forge, PA41.2MShares$1.01 Billion0.02% of portfolio
-
Black Rock Inc. New York, NY25.6MShares$627 Million0.07% of portfolio
-
Baillie Gifford & CO21.8MShares$536 Million0.44% of portfolio
-
State Street Corp Boston, MA17.3MShares$424 Million0.02% of portfolio
-
Geode Capital Management, LLC Boston, MA8.88MShares$218 Million0.02% of portfolio
About Moderna, Inc.
- Ticker MRNA
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 391,200,000
- Market Cap $9.6B
- Description
- Moderna, Inc., a biotechnology company, discovers, develops, and commercializes messenger RNA therapeutics and vaccines for the treatment of infectious diseases, immuno-oncology, rare diseases, cardiovascular diseases, and auto-immune diseases in the United States, Europe, and internationally. Its respiratory vaccines include COVID-19, flu, resp...